Page 3 - Randomized Trials News Today

Central’s Shuger Fox and Cheek Published in Neurology Journal

Structural biases within health systems may account for delays, regardless of individual patient race, according to new data.

The American Heart Association (AHA) Scientific Sessions 2022 in Chicago, and virtually, is set for November 5-7 at McCormick Place. Highly-anticipated clinical trial breakthroughs and discoveries of the year will be offered in both late-breaking scientific sessions and featured science sessions.

Local treatment failure in patients with intermediate- and high-risk prostate cancer predicts a higher risk for metastatic disease.

Our popular daily links, including shadows on the moon, the Fourth of July, crabs, climate change ad plants, wastewater studies, mortality and the health care system, mRNA vaccines, China buys Airbus jets, Myanamr, Samsung beets TSMC, fall of Lysychansk, Russian gas,, Hanoi, bitcoin, abortion

Peter Doshi is an author of this paper. This paper puts my status as a "misinformation spreader" in serious jeopardy. They may have to start calling me a "truth teller" soon. [...]

A pre-print study authored by Peter Doshi from the University of Maryland School of Pharmacy reveals that the risk benefit to getting "vaccinated" for the Wuhan coronavirus (Covid-19) [...]

Prostate cancer is the leading cause of cancer in men worldwide, and radiotherapy is one of the common forms of treatment.

/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...

Individual patient data analysis from MARCAP Consortium may be the strongest evidence to date on androgen deprivation therapy use and duration